We are live on ! Find out more
IRD

Opus Genetics
IRD

20 hedge funds and large institutions have $2.34M invested in Opus Genetics in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more capital invested

Capital invested by funds: $804K → $2.34M (+$1.53M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0% more funds holding

Funds holding: 20 → 20 (0)

Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.09M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$582K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.6K
4
Nomura Holdings
Nomura Holdings
Japan
+$13.1K
5
Citadel Advisors
Citadel Advisors
Florida
+$6.53K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$68K
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$9.8K
3
CS
Credit Suisse
Switzerland
-$7K
4
U
UBS
Switzerland
-$6.07K
5
Northern Trust
Northern Trust
Illinois
-$2.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.01M +$1.09M +4,689 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$890K +$582K +2,494 +153%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$125K +$16.6K +71 +14%
Nomura Holdings
4
Nomura Holdings
Japan
$62K +$13.1K +56 +24%
Northern Trust
5
Northern Trust
Illinois
$42K -$2.33K -10 -5%
BMC
6
Benin Management Corp
Connecticut
$38K – – –
VKH
7
Virtu KCG Holdings
New York
$33K +$35.5K +152 New
Bank of America
8
Bank of America
North Carolina
$23K – – –
Goldman Sachs
9
Goldman Sachs
New York
$19K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$19K +$6.53K +28 +47%
GC
11
Guggenheim Capital
Illinois
$18K – – –
State Street
12
State Street
Massachusetts
$16K – – –
Commonwealth Equity Services
13
Commonwealth Equity Services
Massachusetts
$15K -$9.8K -42 -38%
WA
14
WFG Advisors
Texas
$9K – – –
BA
15
BlackRock Advisors
Delaware
$8K – – –
Citigroup
16
Citigroup
New York
$3K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$1K – – –
Canada Life
18
Canada Life
Manitoba, Canada
$1K +$1.4K +6 New
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
– -$68K -319 Closed
CS
21
Credit Suisse
Switzerland
– -$7K -35 Closed
U
22
UBS
Switzerland
– -$6.07K -26 -93%

IRD Hedge Fund Activity: Q3 2013 in Review

20 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2013, worth a combined $2.34M — up 190% from $804K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IRD positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.09M. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $68K sold.

  • 20 institutional investors held Opus Genetics (IRD) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $2.34M of Opus Genetics stock for Q3 2013, up 190% quarter-over-quarter.
  • 3 funds opened new Opus Genetics positions in Q3 2013 and 2 closed out, a net change of +1 holder.
  • The largest Opus Genetics buyer in Q3 2013 was Sabby Management, an estimated $1.09M added.
  • The largest Opus Genetics seller in Q3 2013 was Bank of New York Mellon, an estimated $68K sold.

Based on aggregated 13F filings for Q3 2013.